Brilinta shows promise in phase III clinical trial
Results of a phase III clinical trial suggest that dual…
Results of a phase III clinical trial suggest that dual antiplatelet therapy may improve outcomes for patients with established coronary artery disease (CAD) and type 2 diabetes....